Results 181 to 190 of about 92,933 (286)

Adiponectin Fortifies White Matter After Chronic Hypoperfusion-Induced Vascular Dementia. [PDF]

Stroke
Miao W, Xu F, Pu H, Shan J, Lyu J, Mai TW, Tian Q, Pandya A, Barreiro J, Jiang L, Wang H, Stetler RA, Leak RK, Chen J, Hu X.   +14 more
europepmc   +1 more source

Maternal obesity during lactation as a hypertensive cardiovascular risk factor in the offspring

Experimental Physiology, EarlyView.
Abstract Maternal obesity is a major public health concern, with growing evidence supporting its role in the developmental programming of cardiometabolic disease. Although prenatal mechanisms have been investigated extensively, the contribution of lactation as a postnatal window of cardiovascular (CV) programming remains insufficiently understood ...
Gabriela Arenas, Cristián A. Amador, Susana Contreras‐Duarte   +2 more
wiley   +1 more source

Δ9 Tetrahydrocannabinol and cannabis extracts differentially improve adipoinsular dysfunction in diet‐induced obesity

The Journal of Physiology, EarlyView.
Abstract figure legend THC and extract administered to diet‐induced obese mice reduced body weight and fat storage. Extract, but not THC, improved glucose clearance by a mechanism that may include restoring adipoinsular function. Abstract Diet‐induced obesity (DIO) is associated with dysregulated adipoinsular axis and endocannabinoid system (eCBS ...
Bryant Avalos, Martin Olmos, Courtney P. Wood, Camila Alvarez, Haley M. Read, Parima Udompholkul, Theodore Garland Jr, Nicholas V. DiPatrizio   +7 more
wiley   +1 more source

Identification of alpha1-oleate as a potent regulator of adipokine-dependent metabolism, in bladder cancer tissue. [PDF]

Cancer Metab
Haq F, Chinchankar S, Ambite I, Ahmadi S, Tran H, Nazari A, Brisuda A, Hacek J, Babjuk M, Svanborg C.   +9 more
europepmc   +1 more source

Tirzepatide and SGLT2 Inhibitors for Heart Failure With Preserved Ejection Fraction and Obesity: Entering a New Cardiometabolic Therapeutic Era

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.
Tirzepatide and SGLT2 inhibitors act through distinct but complementary mechanisms in obesity‐related HFpEF: tirzepatide targets adiposity, inflammation, and insulin resistance, while SGLT2 inhibitors improve decongestion, myocardial energetics, and cardiac remodeling.
Zakariye Isak Mohamed, Abdinasir Adam Shidane, Abdullahi Mohamud Abdiasis, Mohamed Hassan Hussein, Ayaanle Osman Ibrahim, Anas Ali Abdi, Kowthar Ismail Hashi, Mohamed Abdullahi Mohamud, Ali Jimale Mohamed   +8 more
wiley   +1 more source

J Pediatr Endocrinol Metab [PDF]

Persons with type 1 diabetes are at increased risk of developing vascular disease. Adiponectin concentrations may play an intermediate role in this process.

core  

Postprandial response of leptin and adiponectin to standardized high-carbohydrate and high-fat meals in adults: A cross-sectional study. [PDF]

PLoS One
Del Razo-Olvera FM, Arias-Marroquín AT, Martínez-Fajardo M, Dávila-Olmedo WE, Cruz Bautista I, Galán-Ramírez GA, Juárez-Martínez L, Gómez-Velasco DV, Guillén-Pineda LE, López Estrada A, Otero-Otero R, Elías-López D, Martagón-Rosado AJ, Aguilar-Salinas C, Soto-Mota A.   +14 more
europepmc   +1 more source

Association Between a Body Shape Index and Epilepsy Among US Adults: Potential Indirect Pathway Through Depressive Symptoms

Brain and Behavior, Volume 16, Issue 8, August 2026.
ABSTRACT Background Epilepsy is a common and disabling brain disorder. Whether a body shape index (ABSI) is associated with epilepsy, and whether depressive symptoms may partly account for this association, remain unclear. Methods We analyzed 13,066 participants from the National Health and Nutrition Examination Survey 2013–2018.
Qiaoduan Feng, Xiujuan Mi, Hongbin Tang, Shaokun Yang, Can Wan, Jinsong You, Jun Tang   +6 more
wiley   +1 more source

A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study of Adiponectin Agonist (PEG)-BHD1028 in People With Insulin Resistance. [PDF]

Clin Transl Sci
Lapuerta P, Kim BB.
europepmc   +1 more source

Vector‐based comparison as a novel framework for assessing multi‐endpoint clinical trials: Applications to actual data

Clinical and Translational Discovery, Volume 6, Issue 4, August 2026.
Multi‐endpoint clinical trials face long‐standing statistical challenges. Vector‐based comparison (VBC) decomposes endpoints into orthogonal components. Applied to five clinical trials, it reduced confidence‐interval widths by about 50%, indicating higher statistical power, without altering the clinical meaning of endpoints.
Maria Kokkali, Vangelis D. Karalis
wiley   +1 more source